Pharmaceutical

The global pharmaceutical industry is undergoing a consolidation phase in order to combat price pressure, competition and patent cliffs. Innovation is of vital importance for steady growth of pharmaceutical companies. Pharmaceutical companies have been mainly dependent on a few blockbuster molecules. However,with rapid decline in research and development (R&D) productivity and non-conducive regulatory environment, companies need to find different avenues of growth. The patent expiry of blockbuster drugs is expected to pave way for generics. Due to difference in genetic composition of varied individuals, innovation is becoming more complex.This is influencing players offering complementary products and services to collaborate for new product development.

There are four major factors that are impacting the value creation in pharmaceutical industry:

  • Market
    • Stress from patent expiries, niche marketing, and patient-centricity is challenging the growth plans of pharmaceutical companies. Moreover, in emerging markets, companies face strong competition from local players,who sell product at a much lower cost. To counter the same global companies need to significantly reduce their profit margins.
  • Technology
    • Rapid integration of healthcare and information technology is posing threat for current blockbuster drugs
    • Products based on new technologies offer superior properties and are more efficient as compared to existing products in the market
  • Regulation
    • There is constant price pressure from governments to meet demands of growing number of patients
    • Emerging markets have regulatory uncertainty, where decisions are made to protect the interests of the general population
    • Moreover, governments, especially in emerging economies are encouraging pharmaceutical companies to focus on preventive measures for diseases, which involves major investments
  • Innovation
    • Need for innovative products or therapies is rising constantly due to rising pressure of patent-cliff coupled with reducing profit margins
    • Identification of new bacterial and viral strains is driving the need for novel drugs

Demand for personalized medicines is increasing in order to ensure effective treatment of various diseases

Investments in R&D for oncology and NCDs are increasing globally in order to provide cost-effective solutions available to ailing patients.

Market Challenges

The industry is facing certain challenges such as patent cliff, cost pressure and regulatory uncertainties across the globe. This is hindering market growth to a certain extent. Moreover, regulatory authorities are becoming more stringent with the drug approval process. However, with respect to drugs for rare diseases, the FDA has offered a fast-track approval process. Moreover, demand for cost-effective treatment for chronic and non-communicable diseases such as diabetes, hypertension, thyroid disorder, obesity, and cancer is increasing. However, there is a dearth of strong products in the pipeline that offer better treatment option with fewer side effects. The fear of side effects and long-term treatment costs is encouraging patients to shift to alternative therapies.

Combating Challenges

Market players need to combat these challenges and keep their pace with the industry to sustain their market share. Mergers, acquisitions, and divestitures of products, companies or business division is a rapidly emerging trend in the market to combat prevalent challenges in the market.Companies are more focused in terms of therapy areas and hence, are divesting less focused therapy businesses. A good example is the swap deal between GSK and Novartis in 2015.

Moreover, pharmaceutical companies are investing in consumer health products,with increasing consumer’s health awareness and emerging trend of self-medication. These trends are encouraging pharmaceutical companies to enter the OTC market and leverage their brand equity among the doctors, chemists and consumers. Companies such as GlaxoSmithKline, Cipla, Pfizer, Merck, Sun Pharma, and Abbott have a focused division or subsidiary for consumer healthcare products and markets.

Moreover, to combat increasing cost pressure, companies are evolving their distribution channel. Establishing facilities or presence through collaboration in regional markets has helped companies meet local demand with reduced costs and delivery time. Emergence of e-pharmacy has resulted in creation of a separate team in the organization to service consumers ordering medicines online. Moreover, companies are connecting with consumers through social media, which helps improve brand visibility. The distribution channel has thus evolved significantly from the decade old channel consisting of only wholesalers and physical retail shops.

Patient-centricity

Patients are increasingly becoming well informed and organized, sometimes demanding for a particular product from prescribers. Therefore, companies need to be more patient-centric in their approach and provide quality care to consumers. Pharmaceutical companies are focusing on established direct to consumer distribution channels and establishing a more strong relationship with them. Moreover, companies are creating a good purchase experience for consumers through different offerings such as post-purchase medical services, engaging the patient through social media and events, and providing regular product alerts and refilling services.

Growth in Emerging Economies

The pharmaceutical industry is rapidly expanding in emerging economies such as Asia Pacific, Africa, and Latin America. These regions possess immense potential for growth of pharmaceutical companies, owing to inadequate access to medicines, growing population and increasing incidence of non-communicable diseases (NCDs). Besides, demand for contract research and manufacturing is also high in these regions. China and India are the largest emerging markets for CRO and CMO. Companies are highly dependent on China for API supply owing to low purchase cost. Overdependence on a single country can pose a challenge for the pharmaceuticals sector in the near future. Therefore, other emerging countries such as India, Brazil and South Africa are encouraging investments in their country. Besides, global companies are establishing their facilities in Asia Pacific, Middle East and Latin America regions to enable close monitoring and servicing of lucrative regional markets.

Conclusion

Pharmaceutical companies need to focus on an integrated, patient-centric, value-driven approach along with technology integration and strategic partnerships in order to capitalize on lucrative growth opportunities in the market. Major global players in the market include Pfizer Inc., Merck & Co., Inc., Bayer AG, GlaxoSmithKline plc., Sanofi, F. Hoffmann-La Roche AG, AstraZeneca plc. and Novartis AG.

There is a paradigm shift in process in the global pharmaceutical industry from product to a ‘Prodice’ (Product and Service) model, to offer affordable, accessible and quality care to patients.

View More

Pharmaceutical Published Insights

Coherent Market Insights Global Allan Herndon Dudley Syndrome Treatment Market

Published Date : Jan 2024

Allan-Herndon-Dudley syndrome (AHDS) is a rare genetic disorder caused by mutations in the MCT8 gene. These mutations result in impaired thyroid hormone transport across the blood-brain barrier. Current treatment options for AHDS are limited and aim to manage symptoms... View more

Coherent Market Insights Global Chaple Disease Therapeutics Market

Published Date : Jan 2024

Chaple syndrome is also known as DAF or CD55 deficiency, which refers to a genetic disorder that is rare in nature and is related to the immune system. CHAPLE is an abbreviated form for ‘CD55 deficiency with hyperactivation of angiopathic thrombosis, complement ... View more

Coherent Market Insights Global Clinical Laboratory Tests Market

Published Date : Jan 2024

Global  clinical laboratory tests market refers to services that are performed to obtain patient-specific diagnostic, screening, and monitoring information by evaluating specimens taken from the human body. Clinical laboratory tests play an important role in dise... View more

Coherent Market Insights Global Cardiovascular Health Supplements Market

Published Date : Jan 2024

Cardiovascular diseases are the leading cause of death globally. According to World Health Organization report 2022, cardiovascular diseases cause over 18 million deaths each year globally. Due to increasing concerns over cardiovascular health, demand for cardiovascul... View more

Coherent Market Insights Global Dental Cleaning Tablets Market

Published Date : Jan 2024

Dental cleaning tablets are small medication tabs that are used for cleaning teeth at home. They are an effective and convenient way for removing dental plaque and cleaning teeth without water or toothbrush. The tablets work by releasing active cleaning agents once th... View more

Coherent Market Insights Global Cell Penetrating Peptide Market

Published Date : Jan 2024

Cell penetrating peptides (CPPs) are short sequences of amino acids that are able to cross cell membranes and deliver attached bioactive cargo such as antibodies, nucleic acids, and chemotherapeutics into cells. Their ability to traverse barriers has made them importa... View more

Coherent Market Insights Global Autoimmune Polyglandular Syndrome Type 1 Market

Published Date : Jan 2024

Autoimmune polyglandular syndrome type 1 (APS1), also known as autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED), is a rare multisystem disorder caused by the autoimmune destruction of several endocrine glands like the adrenals, parathyroid gland... View more

Coherent Market Insights Anti Epileptic Drugs For Pediatrics Market

Published Date : Jan 2024

Epilepsy is a common neurological disorder that affects people of all ages globally. However, it is more prevalent in children as almost 70% of epilepsy cases are diagnosed before reaching adulthood. Anti-epileptic drugs play a crucial role in managing seizures and im... View more

Coherent Market Insights Hepatitis C Drugs Market

Published Date : Jan 2024

Hepatitis C is a liver infection that can lead to serious liver damage. It’s caused by the hepatitis C virus. About 2.4 million people in the U.S. have the disease. But it causes few symptoms, so most of them don't know. The virus spreads through an infected per... View more

Coherent Market Insights Global Bodybuilding Supplements Market

Published Date : Jan 2024

The bodybuilding supplements market has experienced significant growth over the past decade with more individuals focusing on physical fitness and wanting to gain muscle mass or lose weight, the demand for bodybuilding supplements that enhance workout recovery, boost ... View more

Coherent Market Insights Peptide Synthesis Market

Published Date : Jan 2024

Peptides are short chains of amino acid monomers linked by peptide (amide) bonds. They can range from 2 to 50 amino acids in length. There are two main types of peptides: linear peptides, which contain amino acids linked end-to-end in a chain, and cyclic peptides, whi... View more

Coherent Market Insights Global Dupuytrens Disease Market

Published Date : Jan 2024

Dupuytren's disease is a condition that affects the palmar fascia - the fibrous layer of tissue that lies underneath the skin and above the tendons, nerves, blood vessels, and bones in the palm and fingers. In patients with Dupuytren's disease, the fascia thickens and... View more

Coherent Market Insights Global Workout Supplements Market

Published Date : Jan 2024

The global workout supplements market has been witnessing steady growth over the past few years. Workout supplements include products that are consumed to enhance physical performance during exercise and assist in achieving fitness goals. Protein powders, pre-workout ... View more

Coherent Market Insights Global Antidote Market

Published Date : Jan 2024

The global antidote market has been witnessing steady growth over the past few years owing to the growing incidence of poisoning cases across the world. Poisoning can occur accidentally or intentionally through the consumption of toxic chemicals, drugs, or other harmf... View more

Coherent Market Insights Corporate Wellness Market

Published Date : Jan 2024

Corporate wellness initiatives aim to foster an organizational culture of health in order to support and promote a comprehensive approach to employee wellbeing. Providing a corporate wellness solution that goes above and beyond standard wellness initiatives encourages... View more

Coherent Market Insights Global Traditional Medicine Market

Published Date : Jan 2024

Traditional medicine refers to health practices, approaches, knowledge and beliefs incorporating plant, animal and mineral based medicines, spiritual therapies, manual techniques and exercises, applied singularly or in combination to treat, diagnose and prevent illnes... View more

Coherent Market Insights Companion Animal Arthritis Market

Published Date : Jan 2024

Osteoarthritis (OA) is a common condition that affects dogs and cats. It is characterized as a low-grade inflammatory, progressive degenerative joint disease. OA results from degeneration and aberrant repair of articular cartilage in association with alterations in su... View more

Coherent Market Insights Global Nicotine Replacement Therapy Market

Published Date : Dec 2023

Nicotine replacement therapy (NRT) includes a variety of products like patches, gums, lozenges, inhalers, and nasal sprays that help taper nicotine intake for those attempting to quit smoking and other tobacco products. As the health risks of smoking have become more ... View more

Coherent Market Insights Global Small Volume Parenteral Market

Published Date : Dec 2023

The small volume parenteral market consists of parenteral drugs and formulations administered in small volumes usually less than 100 milliliter. Small volume parenteral find widespread application in treating conditions such as diabetes, cancer, infections, and conges... View more

Coherent Market Insights Global Space Medicine Market

Published Date : Dec 2023

Space medicine is a relatively new field that aims to address the complex medical needs of human spaceflight. Some of the main products and areas of focus in space medicine include life support systems, space suits, and pharmaceuticals. Life support systems on spacecr... View more

© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.